Leona E. Ling
14Patents
3h-index
22Co-inventors
52Inventor score
Filing activity: May 13, 2014 → Mar 21, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10239944B2 | Compositions and methods related to engineered Fc constructs | Chemistry; Metallurgy | 8 | Active |
| US11124573B2 | Compositions and methods related to engineered Fc constructs | Chemistry; Metallurgy | 5 | Active |
| US10464996B2 | Methods for the treatment of neurodegeneration | Emerging Cross-Sectional Technologies | 3 | Active |
| US10676526B2 | FcRn antibodies and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US11352415B2 | Methods for the treatment of neurodegeneration | Emerging Cross-Sectional Technologies | 1 | Active |
| US11661456B2 | Sialylated glycoproteins | Chemistry; Metallurgy | 1 | Active |
| US11639923B2 | Methods for predicting response to treatment | Physics | 1 | Active |
| US11345751B2 | FcRn antibodies and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US12391759B2 | Methods related to engineered Fc constructs | Chemistry; Metallurgy | 0 | Active |
| US11732047B2 | FcRn antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11773168B2 | FcRn antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US12071482B2 | Compositions and methods related to engineered Fc constructs | Chemistry; Metallurgy | 0 | Active |
| US12297256B2 | Methods for the treatment of neurodegeneration | Emerging Cross-Sectional Technologies | 0 | Active |
| US12163951B2 | Methods for predicting response to treatment | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.